Aspira Women's Health Inc. announced that it has entered into agreements to provide its testing services to Medicaid plan members in the state of New Hampshire and Washington, D.C equaling nearly a half million covered lives. The state of New Hampshire covers 200,000 lives and Washington D.C. covers 265,000 lives under their respective Medicaid programs. With the addition of these plans, Aspira is now credentialed to provide its OVA1 testing to nearly 80% of the Medicaid population in the U.S., totaling approximately 60 million lives.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.35 USD | -18.18% |
|
+14.41% | -66.91% |
09/07 | Aspira Women's Health Inc. announced that it has received $1.910249 million in funding | CI |
02/07 | Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday Ahead of Powell Speech | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-66.91% | 22.6M | |
-33.38% | 9.17B | |
+19.89% | 4.14B | |
+10.64% | 2.63B | |
-7.42% | 1.95B | |
-26.17% | 1.85B | |
+41.45% | 1.22B | |
+52.58% | 969M | |
-6.77% | 694M | |
-18.99% | 235M |
- Stock Market
- Equities
- AWH Stock
- News Aspira Women's Health Inc.
- Aspira Women's Health Inc. Announces the Addition of 465,000 Covered Lives Through Medicaid Credentialing